About Source Bioscience
Source BioScience plc provides diagnostics and genetic analysis services and products to healthcare and life science research markets primarily in the United Kingdom. The company operates in three segments: Healthcare, LifeSciences, and Stability and Bio Storage. The Healthcare segment offers diagnostics services, including diagnostic testing for cancer and other diseases; and cytology and serology products, such as cervical cancer screening and blood banking serology reagents. The LifeSciences segment provides DNA sequencing services and related products to academic research groups, and biotechnology and pharmaceutical companies through its network of laboratories and distributors. This segment offers GenomeCube, an e-commerce platform, database, and search engine that provides a portfolio of approximately 26 million cDNA clones and 120,000 antibodies; and reSource range of own branded products, primarily focused on the life science research work flow requirements for the DNA extraction and preparation. The Stability and Bio Storage segment provides drug discovery support services, such as biomarker discovery and clinical trial services, and stability storage and sample archiving under environmentally controlled conditions. In addition, the company engages in the provision of diagnostic and genomic services; the distribution of diagnostic and genomic products; and the rental of properties. It also has operations in Europe, the Americas, the Middle East, Asia, and Australasia. The company was formerly known as Medical Solutions plc and changed its name to Source BioScience plc in March 2008. Source BioScience plc was incorporated in 1903 and is headquartered in Nottingham, the United Kingdom.
